Concepedia
Statistics
Publications
14
Citations
1.1K
H-Index
12
Active since
2007
Affiliations
Datar Cancer Genetics (India)(Current)
Worcester Polytechnic Institute
Kokilaben Dhirubhai Ambani Hospital
Deenanath Mangeshkar Hospital and Research Center
Cancer Clinic
Anantbhushan Ranade is an author at Datar Cancer Genetics (India) specializing in medicine, oncology, and pharmacology.
Publications per year
2007–2023
Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer
Harold J. Burstein, Yan Sun, Luc Dirix et al. · Journal of Clinical Oncology · 2010 · 527 citations · Full text
Medicine, Oncology, Pharmacology +17
Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
John V. Heymach, Luis Paz‐Ares, Filippo de Braud et al. · Journal of Clinical Oncology · 2008 · 220 citations
Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India
Anantbhushan Ranade, Deepak Joshi, Girish K. Phadke et al. · Annals of Oncology · 2013 · 57 citations · Full text
Pharmacy, Pharmaceutics, Pharmacology +14
Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
Dadasaheb Akolkar, Darshana Patil, Timothy Crook et al. · International Journal of Cancer · 2019 · 49 citations · Full text
Medicine, Cell Biology, Oncology +17
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
Timothy Crook, Robert Leonard, Kefah Mokbel et al. · Cancers · 2022 · 42 citations · Full text
Medicine, Oncology, Pathology +17
1–5 of 14